QINLOCK cpr 50 mg fl 90 pce
7680681990024
CH-68199
L01EX19
07.16.1.
Reimbursement limitations:
QINLOCK.01
QINLOCK est indiqué à une dose maximale de 150 mg une fois par jour pour …
1 / 3
google
Details
- Product number
- 6819901
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- ripretinibum 50 mg, hypromellosi acetas succinas, cellulosum microcristallinum, lactosum monohydricum 179 mg, crospovidonum, silica colloidalis anhydrica, magnesii stearas, pro compresso.
Articles (1)
Qinlock 50 mg, Tabletten
Tabletten
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
179.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 19940.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
Deciphera Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 68199
- Drug name
- Qinlock, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EX19
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 07/10/2021
- Authorization expiration date
- 06/10/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- QINLOCK cpr 50 mg fl 90 pce
- Description (DE)
- QINLOCK Tabl 50 mg Fl 90 Stk
- Market launch
- 07/10/2021
- Narcotic (BTM)
- No